Position in AZN
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$368,038,553
New position
Shares Held
1,866,132
first reported quarter
Ownership
0.120%
of shares outstanding
% of Portfolio
1.16%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 95.88646462308132.ToString("F0")%
Shared 0.ToString("F0")%
None 4.113535376918675.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Bank Julius Baer & Co. Ltd, Zurich holds $2,442,122,150 across 12 Drug Manufacturers - General names. AZN ranks #4 (15.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
885,763 | $814,698,234 | |
| 2 | JNJ |
Johnson & Johnson
|
2,765,022 | $675,881,977 | |
| 3 | MRK |
Merck & Co., Inc.
|
3,700,222 | $445,099,704 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
1,866,132 | $368,038,553 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
1,280,971 | $77,690,891 | |
| 6 | ABBV |
AbbVie Inc.
|
124,985 | $27,182,987 | |
| 7 | PFE |
Pfizer Inc
|
913,851 | $25,660,936 | |
| 8 | AMGN |
Amgen Inc
|
16,296 | $5,733,747 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $368,038,553 | 1,866,132 | Shares | Sole | 2026-05-05 | |
| No filing history on record for this holder in this stock. | ||||||